Ken Ohmine

2.5k citations

82 papers · 1.4k indexed · h-index 21

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 36
- Acute Myeloid Leukemia Research 16
- Chronic Myeloid Leukemia Treatments 10
- Hematopoietic Stem Cell Transplantation 9
Genetics 21
- Chronic Lymphocytic Leukemia Research 12

Co-authors: Tetsuya Terasaki Sumio Ohtsuki Keiya Ozawa Yasuo Uchida Junichi Kamiie Ryo Iwase Shingo Ito Yuki Katsukura
Journals: International Journal of Hematology (10 papers)Blood (10 papers)Annals of Hematology (4 papers)Leukemia Research (3 papers)Experimental Hematology (3 papers)
Partner nations: Japan United States Poland

In The Last Decade

Ken Ohmine

80 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ken Ohmine

Since Specialization

Citations

This map shows the geographic impact of Ken Ohmine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ohmine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ohmine more than expected).

Fields of papers citing papers by Ken Ohmine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Ohmine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ohmine. The network helps show where Ken Ohmine may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ken Ohmine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Ohmine Line = papers co-authored together Ken Ohmine links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era International Journal of Hematology ·Yumiko Toda, Masahiro Ashizawa, J. Rosenberg, 宣荣喜, Takashi Ikeda, Shin‐ichiro Kawaguchi, Takashi Nagayama, Kento Umino, 曺永憲, Kaoru Morita, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Shin‐ichiro Fujiwara, Ken Ohmine, Yoshinobu Kanda	2024	0
2	Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors European Journal Of Haematology ·Iin Maryam Lestusen, Rachel Killean, T. Letzel, Usanarat Anurathapan, Teeraya Puavilai, Pimjai Niparuck, Pichika Chantrathammachart, 純夫加本, Kitipong Uaesoontrachoon, Ryosuke Uchibori, Kate Swain, Ken Ohmine, Suradej Hongeng	2023	1
3	Novel immunotherapies in multiple myeloma International Journal of Hematology ·Ken Ohmine, Ryosuke Uchibori	2022	7
4	Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial International Journal of Hematology ·Hirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, Yoshinobu Kanda, Ken Ohmine, Takaaki Ono, Itaru Matsumura, Maho Ishikawa, Gail Mcdaniel, Akio Maki, Hirohiko Shibayama	2021	8
5	Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement Hematology ·Kento Umino, Shin‐ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Ramagiri Brahmini, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	2018	20
6	Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation ·Yasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa, Владислав Вадимович Гут, Anastasiia Poritska, Ryoji Ito, Kiyomi Mashima, Iekuni Oh, 曺永憲, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Shin‐ichiro Fujiwara, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	2018	24
7	Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial International Journal of Hematology ·Hirohisa Nakamae, Tetsuya Fukuda, Chiaki Nakaseko, Yoshinobu Kanda, Ken Ohmine, Takaaki Ono, Itaru Matsumura, Akira Matsuda, Gail Mcdaniel, Kazuo Itô, Hirohiko Shibayama	2017	21
8	Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia Annals of Hematology ·Shoko Ito, Shin‐ichiro Fujiwara, Kiyomi Mashima, Kento Umino, Ramagiri Brahmini, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi, Yoshinobu Kanda	2017	9
9	Mechanisms of resistance to azacitidine in human leukemia cell lines Experimental Hematology ·A. Madejski, Tadashi Nagai, Pu Hui Meng, Hiroyuki Kobayashi, Tomonori Tsukahara, Ken Ohmine, Kazuo Muroi, Keiya Ozawa	2013	37
10	CD56 Expression in Normal Immature Granulocytes after Allogeneic Hematopoietic Stem Cell Transplantation Journal of Clinical and Experimental Hematopathology ·Kazuo Muroi, Shin‐ichiro Fujiwara, Raine Tatara, Miyuki Sugimoto, Chihiro Yamamoto, 土田恭代, Akiko Meguro, Kaoru Hatano, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Keiya Ozawa	2013	6
11	Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics Molecular Pharmacology ·Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori, Tetsuya Terasaki	2012	21
12	Flow Cytometric Analysis of Kappa and Lambda Light Chain Expression in Endoscopic Biopsy Specimens before the Diagnosis of B-Cell Lymphoma Journal of Clinical and Experimental Hematopathology ·Satoko Oka, Kazuo Muroi, Kazuya Sato, Shin‐ichiro Fujiwara, Iekuni Oh, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, Tadashi Nagai, Noriyoshi Fukushima, Akira Tanaka, Kate Swain	2012	4
13	Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells Biochemical Pharmacology ·Kozue Yoshida, Tadashi Nagai, Ken Ohmine, Pu Hui Meng, A. Madejski, Yoji Ishida, Keiya Ozawa	2011	8
14	Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways Leukemia Research ·Tadashi Nagai, Ken Ohmine, Shin‐ichiro Fujiwara, Pu Hui Meng, E. S. Edwards, Keiya Ozawa	2010	6
15	Tracking of Specific Integrant Clones in Dogs Treated with Foamy Virus Vectors Human Gene Therapy ·Ken Ohmine, Yi Li, Thomas R. Bauer, Dennis D. Hickstein, David W. Russell	2010	7
16	Long-Term Results of Dose-Intensive Chemotherapy With G-CSF Support (TCC-NHL-91) for Advanced Intermediate-Grade Non-Hodgkin's Lymphoma: A Review of 59 Consecutive Cases Treated at a Single Institute Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Miyuki Akutsu, Saburo Tsunoda, Tohru Izumi, Masaru Tanaka, Susumu Katano, Kōichi Inoue, Seiji Igarashi, Kaoru Hirabayashi, Yusuke Furukawa, Ken Ohmine, Kazuya Sato, Hiroyuki Kobayashi, Keiya Ozawa, Keita Kirito, Mira Bartok, Satoshi Teramukai, Masanori Fukushima, Yasuhiko Kano	2008	2
17	Flow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report Satoko Oka, Andżelika Serwatka, Kazuya Sato, Enzhu Wei, Masuzu Ueda, Yoko Ono, Tomohiro Matsuyama, Norhisam Misron, Ken Ohmine, Laura Staliunaite, Masaaki Takatoku, Masaki Mori, Tadashi Nagai, Frank M. Kyes	2007	2
18	Cloning and characterization of a human BCR/ABL-positive cell line, K562/RR, resistant to the farnesyltransferase inhibition by tipifarnib Experimental Hematology ·Takuji Miyoshi, Tadashi Nagai, Satoru Kikuchi, Ken Ohmine, Makiko Nakamura, Toshiaki Hanafusa, Norio Komatsu, Keiya Ozawa	2007	4
19	Clinical significance of flow cytometric evaluation of bone marrow involvement in B-cell lymphoma Enzhu Wei, Andżelika Serwatka, Tohru Izumi, Kazuya Sato, Masuzu Ueda, Tomohiro Matsuyama, Ken Ohmine, Norhisam Misron, Laura Staliunaite, Masaaki Takatoku, Masaki Mori, Tadashi Nagai, Kate Swain	2006	1
20	GATA Suppresses Erythropoietin Gene Expression through GATA Site in Mouse Erythropoietin Gene Promoter International Journal of Hematology ·Shigehiko Imagawa, Norio Suzuki, Ken Ohmine, Naoshi Obara, Harumi Y. Mukai, Keiya Ozawa, Masayuki Yamamoto, Toshiro Nagasawa	2002	21

About Ken Ohmine

Ken Ohmine is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 82 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Hematology (368 citations), Genetics (210 citations), Oncology (528 citations), Molecular Biology (605 citations) and Cancer Research (124 citations). Ken Ohmine has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Tetsuya Terasaki, Sumio Ohtsuki, Keiya Ozawa, Yasuo Uchida, Junichi Kamiie, Ryo Iwase, Shingo Ito, Yuki Katsukura, Tadashi Nagai and Kazuo Muroi. Their work appears in journals such as International Journal of Hematology, Blood, Annals of Hematology, Leukemia Research and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact